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Purpose of the study
There is a global trend for declining HIV-1 resistance over
time in antiretroviral-experienced patients. We aimed to
investigate if the decreasing resistance to N(t)RTIs and PIs
among the treated patients in Greece during 1999–2006,
is correlated with the administration of any particular
drugs.
Methods
HIV-1 genotypic resistance was determined from 1,327
treated patients failing on the first treatment regimen
(HIV-RNA >1000 copies/mL) later than 1998. All
sequences along with a detailed treatment history record
were stored in a HIV sequence database. Potential associ-
ation between the levels of resistance and the percentage
of drugs received before resistance testing per year was
explored by estimating the slope of change in the propor-
tion of resistant strains over increasing drug use.
Summary of results
Increased duration of TDF was associated with decreasing
levels of resistance (p < 0.001). The slope of change in %
resistance for 10% increase in drug administration was -
0.026. A similar trend was observed also for ABC (slope: -
0.078, p < 0.001). On the other hand, increased use for
ZDV, 3TC and d4T was associated with increasing resist-
ance (p < 0.001). No trend was found for ddI. Decreasing
resistance to PIs was associated with boosted PIs such as
bLPV (slope: -0.038, p < 0.001), bATV (slope: -0.119, p <
0.001) and bTPV (slope: -0,126, p < 0.001), but not for
bSQV(slope:0.62, p < 0.001). Similarly elevating resist-
ance was correlated with increased use for IDV (slope:
0.051, p < 0.001), SQV (slope: 0.093, p < 0.001), RTV
(slope: 0.074, p < 0.001) and NLF (slope: 0.036, p =
0.019).
Conclusion
Patterns of resistance over time are correlated in a differ-
ent way with the administration of particular drugs.
Importantly, ABC, TDF and boosted PIs (bLPV, bATV and
bTPV) are associated with decreasing resistance to
N(t)RTIs and PIs during 1999–2006.
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